197 related articles for article (PubMed ID: 34169939)
1. A light and hypoxia-activated nanodrug for cascade photodynamic-chemo cancer therapy.
Zhong Y; Huang S; Zheng C; Huang J; Li B; Han S; Xiao H; Wang Y; Shuai X
Biomater Sci; 2021 Jul; 9(15):5218-5226. PubMed ID: 34169939
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery.
Guo X; Han L; Chen W; He H; Zhang W; Huang C; Wang X
Int J Nanomedicine; 2024; 19():247-261. PubMed ID: 38229704
[TBL] [Abstract][Full Text] [Related]
3. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
[TBL] [Abstract][Full Text] [Related]
4. Light-triggered theranostic liposomes for tumor diagnosis and combined photodynamic and hypoxia-activated prodrug therapy.
Zhang K; Zhang Y; Meng X; Lu H; Chang H; Dong H; Zhang X
Biomaterials; 2018 Dec; 185():301-309. PubMed ID: 30265899
[TBL] [Abstract][Full Text] [Related]
5. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
[TBL] [Abstract][Full Text] [Related]
7. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
8. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
[TBL] [Abstract][Full Text] [Related]
9. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
11. Ce6-C6-TPZ co-loaded albumin nanoparticles for synergistic combined PDT-chemotherapy of cancer.
Sun X; Sun J; Lv J; Dong B; Liu M; Liu J; Sun L; Zhang G; Zhang L; Huang G; Xu W; Xu L; Bai X; Song H
J Mater Chem B; 2019 Oct; 7(38):5797-5807. PubMed ID: 31483422
[TBL] [Abstract][Full Text] [Related]
12. Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy.
Cheng G; Tao S; Liu S; Wang P; Zhang C; Liu J; Hao C; Wang S; Guo D; Xu B
ACS Macro Lett; 2024 May; 13(5):599-606. PubMed ID: 38683197
[TBL] [Abstract][Full Text] [Related]
13. Stepwise-activatable hypoxia triggered nanocarrier-based photodynamic therapy for effective synergistic bioreductive chemotherapy.
Ihsanullah KM; Kumar BN; Zhao Y; Muhammad H; Liu Y; Wang L; Liu H; Jiang W
Biomaterials; 2020 Jul; 245():119982. PubMed ID: 32224374
[TBL] [Abstract][Full Text] [Related]
14. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer.
Ma J; Tai Z; Li Y; Li Y; Wang J; Zhou T; Shen M; Xin R; Shen C; Zhu Q; Chen Z
Int J Nanomedicine; 2024; 19():2057-2070. PubMed ID: 38482522
[TBL] [Abstract][Full Text] [Related]
15. Photo-triggered self-destructive ROS-responsive nanoparticles of high paclitaxel/chlorin e6 co-loading capacity for synergetic chemo-photodynamic therapy.
Yang X; Shi X; Zhang Y; Xu J; Ji J; Ye L; Yi F; Zhai G
J Control Release; 2020 Jul; 323():333-349. PubMed ID: 32325174
[TBL] [Abstract][Full Text] [Related]
16. Novel carrier-free nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6: Self-assembly mechanism investigation and in vitro/in vivo evaluation.
Zhao Y; Zhao Y; Ma Q; Zhang H; Liu Y; Hong J; Ding Z; Liu M; Han J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110722. PubMed ID: 31887649
[TBL] [Abstract][Full Text] [Related]
17. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
19. Enhanced chemo-photodynamic therapy of an enzyme-responsive prodrug in bladder cancer patient-derived xenograft models.
Tan P; Cai H; Wei Q; Tang X; Zhang Q; Kopytynski M; Yang J; Yi Y; Zhang H; Gong Q; Gu Z; Chen R; Luo K
Biomaterials; 2021 Oct; 277():121061. PubMed ID: 34508957
[TBL] [Abstract][Full Text] [Related]
20. Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy.
Zhang Y; Huang F; Ren C; Yang L; Liu J; Cheng Z; Chu L; Liu J
ACS Appl Mater Interfaces; 2017 Apr; 9(15):13016-13028. PubMed ID: 28378992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
